Last updated: 2026-10-15 08:40:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $164.99, with a market capitalization of $241.66B and a P/E ratio of 113.14. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
$241.66B | |
$162.15 | |
$212.71 | |
$29.96 | |
$162.03 | |
4.13K | |
3.32M | |
113.14 | |
$212.71 | |
$153.41 | |
1.41% | |
2001-12-30 |
AstraZeneca PLC (AZN) is trading at $164.99 in pre-market trading as of 2026-10-15 08:24:41, up 1.83% ($2.96) from the previous close of $162.03
Pre-market trading shows how investors are pricing AZN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, AstraZeneca PLC (AZN) moved from $158.61 to $164.99, representing a gain of 4.02% ($6.38).
The stock traded between $154.00 and $165.30 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 2.77 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 19.5%
AZN is currently trading at $164.99, placing it 19.5% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
| Employees | 96100 |
| CEO | Pascal Claude Roland Soriot |
| Founded | 1992 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.